An Introduction to the International Journal of Particle Therapy's Special Issue on Particle Therapy for Head and Neck Malignancies

S. Frank
{"title":"An Introduction to the International Journal of Particle Therapy's Special Issue on Particle Therapy for Head and Neck Malignancies","authors":"S. Frank","doi":"10.14338/2331-5180-8.1.1","DOIUrl":null,"url":null,"abstract":"Particle therapy has emerged as a standard-of-care treatment option in the management of head and neck malignancies owing to its unique physical and biologic properties that lead to improved clinical outcomes. Likewise, the value of particle therapy in the management of head and neck tumors has rapidly evolved over the past decade, and head and neck cancer management currently represents one of the most common indications for the use of proton therapy. It is therefore my privilege to introduce this special IJPT Particle Therapy for Head and Neck Malignancies issue, which offers 33 articles by renowned international authors knowledgeable in head and neck cancer management, making it, to date, the most definitive guide to this new standard of care. The research presented herein expands our knowledge of the biologic enhancement effect of proton therapy, the physical properties that require unique and complex treatment planning approaches, and the resulting improvement in long-term clinical outcomes. Further clarity has been provided on the use of advanced Monte Carlo and LET-based treatment planning and quality assurance methods for emerging treatment centers, thereby minimizing the risk of unnecessary side effects and complications. Additional opportunities are offered for personalization of particle therapy through combining its biologic enhancement effects with concurrent systemic therapy. From pediatrics to adults, the issue seeks to advance health policy and improve patient access with model-based selection, activity-based costing, cost-effectiveness, financial toxicity, and work productivity outcomes. I would like to dedicate this special issue to our head and neck cancer patients worldwide who have participated in the clinical trials and research protocols that have resulted in these publications, thereby advancing our knowledge and standard of care for future patients. like dedicate this special issue to my parents and family, who have constant support to see this project to completion.","PeriodicalId":36923,"journal":{"name":"International Journal of Particle Therapy","volume":"8 1","pages":"1 - 2"},"PeriodicalIF":2.1000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Particle Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14338/2331-5180-8.1.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Particle therapy has emerged as a standard-of-care treatment option in the management of head and neck malignancies owing to its unique physical and biologic properties that lead to improved clinical outcomes. Likewise, the value of particle therapy in the management of head and neck tumors has rapidly evolved over the past decade, and head and neck cancer management currently represents one of the most common indications for the use of proton therapy. It is therefore my privilege to introduce this special IJPT Particle Therapy for Head and Neck Malignancies issue, which offers 33 articles by renowned international authors knowledgeable in head and neck cancer management, making it, to date, the most definitive guide to this new standard of care. The research presented herein expands our knowledge of the biologic enhancement effect of proton therapy, the physical properties that require unique and complex treatment planning approaches, and the resulting improvement in long-term clinical outcomes. Further clarity has been provided on the use of advanced Monte Carlo and LET-based treatment planning and quality assurance methods for emerging treatment centers, thereby minimizing the risk of unnecessary side effects and complications. Additional opportunities are offered for personalization of particle therapy through combining its biologic enhancement effects with concurrent systemic therapy. From pediatrics to adults, the issue seeks to advance health policy and improve patient access with model-based selection, activity-based costing, cost-effectiveness, financial toxicity, and work productivity outcomes. I would like to dedicate this special issue to our head and neck cancer patients worldwide who have participated in the clinical trials and research protocols that have resulted in these publications, thereby advancing our knowledge and standard of care for future patients. like dedicate this special issue to my parents and family, who have constant support to see this project to completion.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
《国际粒子治疗杂志》头颈部恶性肿瘤粒子治疗特刊简介
粒子治疗因其独特的物理和生物特性而成为头颈部恶性肿瘤治疗的标准治疗选择,可改善临床效果。同样,粒子治疗在头颈部肿瘤治疗中的价值在过去十年中迅速发展,头颈部癌症治疗目前是质子治疗最常见的适应症之一。因此,我很荣幸介绍这期IJPT粒子治疗头颈部恶性肿瘤特刊,该特刊提供了33篇由熟悉头颈部癌症管理的著名国际作家撰写的文章,使其成为迄今为止这一新护理标准的最权威指南。本文介绍的研究扩展了我们对质子治疗的生物增强作用、需要独特而复杂的治疗计划方法的物理特性以及由此带来的长期临床结果改善的了解。进一步明确了在新兴治疗中心使用先进的蒙特卡洛和基于LET的治疗计划和质量保证方法,从而将不必要的副作用和并发症的风险降至最低。通过将粒子治疗的生物增强效果与同时进行的全身治疗相结合,为粒子治疗的个性化提供了额外的机会。从儿科到成人,该问题旨在通过基于模型的选择、基于活动的成本计算、成本效益、财务毒性和工作效率结果来推进卫生政策,改善患者的就医机会。我想把这期特刊献给我们全世界的癌症头颈部患者,他们参与了临床试验和研究方案,并发表了这些出版物,从而提高了我们对未来患者的知识和护理标准。我想把这期特刊献给我的父母和家人,他们一直支持我完成这个项目。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Particle Therapy
International Journal of Particle Therapy Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
3.70
自引率
5.90%
发文量
23
审稿时长
20 weeks
期刊最新文献
Impact of COVID-19 Pandemic on Carbon-Ion Radiation Therapy in Japan: A Japanese National Registry Study. The Level of Circulating M-MDSCs as an Indicator for the Therapeutic Outcome of BNCT in End-Stage Malignant Brain Tumor Patients. Vaginal Mucosal Melanoma Cell Activation in Response to Photon or Carbon Ion Irradiation. Navigating a New Frontier: Evaluating Leadless Pacemakers in Proton Therapy. Cardiac Conduction System as an OAR in Radiation Therapy: Doses to SA/AV Nodes and Their Reduction.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1